Belfast, United Kingdom

Christopher Curtis Allen

This inventor holds 2 USPTO granted patents. Top assignee: Zeneca Limited. Active years: 1998-2000.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christopher Curtis Allen: Innovator in Biochemical Processes

Introduction

Christopher Curtis Allen is a notable inventor based in Belfast, GB. He has made significant contributions to the field of biochemistry, particularly in the resolution of complex chemical compounds. With a total of 2 patents, Allen's work has implications for the pharmaceutical and agrochemical industries.

Latest Patents

One of Allen's latest patents is titled "Process for the resolution of cis 1,2-indane diols using Pseudomonas." This innovative process involves treating a mixture of dihydroxydihydroindene enantiomers with a Pseudomonas putida species microorganism. The resolved dihydroxydihydroindenes produced through this method serve as valuable intermediates for synthesizing biologically active compounds, including pharmaceuticals and agrochemicals.

Career Highlights

Christopher Curtis Allen is currently associated with Zeneca Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in creating effective and sustainable chemical solutions.

Collaborations

Throughout his career, Allen has collaborated with esteemed colleagues such as Howard Dalton and Derek Raymond Boyd. These partnerships have enriched his research and contributed to the success of his innovative projects.

Conclusion

Christopher Curtis Allen stands out as a key figure in the field of biochemistry, with his patents paving the way for advancements in pharmaceutical and agrochemical applications. His contributions reflect a commitment to innovation and excellence in scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…